Literature DB >> 9093257

32 bp CCR-5 gene deletion and resistance to fast progression in HIV-1 infected heterozygotes.

J Rappaport, Y Y Cho, H Hendel, E J Schwartz, F Schachter, J F Zagury.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9093257     DOI： 10.1016/S0140-6736(05)62697-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  21 in total

1.  Pathogenesis of primary R5 human immunodeficiency virus type 1 clones in SCID-hu mice.

Authors:  R M Scoggins; J R Taylor; J Patrie; A B van't Wout; H Schuitemaker; D Camerini
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Multiple-cohort genetic association study reveals CXCR6 as a new chemokine receptor involved in long-term nonprogression to AIDS.

Authors:  Sophie Limou; Cédric Coulonges; Joshua T Herbeck; Daniëlle van Manen; Ping An; Sigrid Le Clerc; Olivier Delaneau; Gora Diop; Lieng Taing; Matthieu Montes; Angélique B van't Wout; Geoffrey S Gottlieb; Amu Therwath; Christine Rouzioux; Jean-François Delfraissy; Jean-Daniel Lelièvre; Yves Lévy; Serge Hercberg; Christian Dina; John Phair; Sharyne Donfield; James J Goedert; Susan Buchbinder; Jérôme Estaquier; François Schächter; Ivo Gut; Philippe Froguel; James I Mullins; Hanneke Schuitemaker; Cheryl Winkler; Jean-François Zagury
Journal:  J Infect Dis       Date:  2010-09-15       Impact factor: 5.226

3.  Expression and function of chemokine receptors on human thymocytes: implications for infection by human immunodeficiency virus type 1.

Authors:  J R Taylor; K C Kimbrell; R Scoggins; M Delaney; L Wu; D Camerini
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

Review 4.  Stem cell-based anti-HIV gene therapy.

Authors:  Scott G Kitchen; Saki Shimizu; Dong Sung An
Journal:  Virology       Date:  2011-01-17       Impact factor: 3.616

5.  Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 delta32.

Authors:  N L Michael; J A Nelson; V N KewalRamani; G Chang; S J O'Brien; J R Mascola; B Volsky; M Louder; G C White; D R Littman; R Swanstrom; T R O'Brien
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

6.  Effect of TNF-alpha genetic variants and CCR5 Delta 32 on the vulnerability to HIV-1 infection and disease progression in Caucasian Spaniards.

Authors:  Sergi Veloso; Montserrat Olona; Felipe García; Pere Domingo; Carlos Alonso-Villaverde; Montserrat Broch; Joaquim Peraire; Consuelo Viladés; Montserrat Plana; Enric Pedrol; Miguel López-Dupla; Carmen Aguilar; Mar Gutiérrez; Agathe Leon; Mariona Tasias; Josep Ma Gatell; Cristóbal Richart; Francesc Vidal
Journal:  BMC Med Genet       Date:  2010-04-26       Impact factor: 2.103

7.  Associations of the IL2Ralpha, IL4Ralpha, IL10Ralpha, and IFN (gamma) R1 cytokine receptor genes with AIDS progression in a French AIDS cohort.

Authors:  Hervé Do; Alexandre Vasilescu; Gora Diop; Thomas Hirtzig; Cédric Coulonges; Taoufik Labib; Simon C Heath; Jean-Louis Spadoni; Amu Therwath; Mark Lathrop; Fumihiko Matsuda; Jean-François Zagury
Journal:  Immunogenetics       Date:  2006-02-21       Impact factor: 2.846

8.  Multistage genomewide association study identifies a locus at 1q41 associated with rate of HIV-1 disease progression to clinical AIDS.

Authors:  Joshua T Herbeck; Geoffrey S Gottlieb; Cheryl A Winkler; George W Nelson; Ping An; Brandon S Maust; Kim G Wong; Jennifer L Troyer; James J Goedert; Bailey D Kessing; Roger Detels; Steven M Wolinsky; Jeremy Martinson; Susan Buchbinder; Gregory D Kirk; Lisa P Jacobson; Joseph B Margolick; Richard A Kaslow; Stephen J O'Brien; James I Mullins
Journal:  J Infect Dis       Date:  2010-02-15       Impact factor: 5.226

9.  A haplotype of the human CXCR1 gene protective against rapid disease progression in HIV-1+ patients.

Authors:  A Vasilescu; Y Terashima; M Enomoto; S Heath; V Poonpiriya; H Gatanaga; H Do; G Diop; T Hirtzig; P Auewarakul; D Lauhakirti; T Sura; P Charneau; S Marullo; A Therwath; S Oka; S Kanegasaki; M Lathrop; K Matsushima; J-F Zagury; F Matsuda
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-21       Impact factor: 11.205

10.  Genomic analysis of Fas and FasL genes and absence of correlation with disease progression in AIDS.

Authors:  A Vasilescu; S C Heath; G Diop; H Do; T Hirtzig; H Hendel; S Bertin-Maghit; J Rappaport; A Therwath; G M Lathrop; F Matsuda; J-F Zagury
Journal:  Immunogenetics       Date:  2004-03-23       Impact factor: 2.846
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.